Transforming Canadians’ lives
Partnering to champion policies that drive the discovery, development and delivery of transformative medicines and vaccines.
BENEFITS OF INNOVATIVE MEDICINES
Real hope for patients and families
New medicines and vaccines save lives and help make our healthcare system more cost‑effective.
Transformation
Preventing or curing disease means extending lives, relieving suffering and improving people’s quality of life.
Safety
Promoting a robust regulatory protocol means ensuring safe and effective medicines for Canadians.
Sustainability
Supporting sustainable healthcare means we all spend more time enjoying life and being productive.
Industry impact In Canada
Better Health Outcomes
47
Innovative Medicines Canada members
110,000
High-quality Canadian jobs
$18.4 billion
Total yearly economic impact
LATEST RESOURCES
The Canadian Research and Development Pharmaceutical Sector, 2022
This study examines the contribution of Canada’s research and development (R&D) pharmaceutical sector to the Canadian economy in 2022. It builds upon the annual reports produced since 2018.
Canadian Drug Access Pathway
The process for Canadians to access new medicines is extremely complex and involves several different federal, provincial, and territorial agencies. It takes two years following approval (736 days) for Canadian patients to get access to a drug in the public plan, whereas those in the private plan get access to a drug in less than one year (226 days).
Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget
LATEST PRESS RELEASES
Press Release June 12, 2025
Pharmaceutical Industry Calls on G7 to Prioritize Innovation as Strategic Pillar for Health, Growth and Security
Geneva and Ottawa, June 12 – Ahead of the upcoming G7 Leaders’ Summit, the global pharmaceutical industry, represented by the […]
Press Release May 12, 2025
New Statistics Canada Data Reinforces Life Sciences as an Economic Engine
Innovative Pharmaceutical Industry Contributed $18.4 Billion to the Canadian Economy in 2022 Ottawa, May 12, 2024 – New data released […]
Press Release May 05, 2025
2025 Diversity and Equity in Research Award Nominations Now Open
Nominate Trailblazers in Health Equity Ottawa, May 5, 2025 – The Health Research Foundation (HRF) of Innovative Medicines Canada is […]
Press Release April 29, 2025
IMC Congratulates Canada’s New Government and Looks Forward to Advancing Access to Innovative Medicines
Ottawa, ON – Innovative Medicines Canada (IMC) congratulates Mark Carney on his election as Canada’s Prime Minister, the Liberal Party […]
Press Release April 23, 2025
Nominations are now Open for the 2025 Health Research Foundation’s Medal of Honour
NOMINATE OUTSTANDING CONTRIBUTIONS TO HEALTH SCIENCES, POLICY, AND RESEARCH BY JULY 15, 2025 Ottawa, April 23 – The Health Research […]
Press Release April 01, 2025
All Provinces and Territories Sign Rare Disease Drug Agreements
Ottawa, April 1, 2025 – Quebec signed a bilateral agreement under the federal government’s National Strategy for Drugs for Rare […]
Press Release March 21, 2025
IMC Calls for Pharmacare Reform to Ensure Access to Innovative Medicines and Protect Personalized Care
Ottawa, March 21, 2025 – With the imminent announcement of a federal election, Canadians have an opportunity to reflect on the […]
Press Release December 16, 2024
Innovative Medicines Canada Applauds Premiers’ Agreement at 2024 Council of the Federation Meeting to Accelerate Access to Life-Saving Medications
Toronto, December 16, 2024 – Innovative Medicines Canada (IMC) welcomes the collective agreement amongst Canada’s Premiers to take meaningful action […]
